Pharmiva is an innovation driven company with a focus on diseases related to women’s health. We develop and market products based on a unique expert knowledge within research and development of medical products aimed for local administration.

Major shareholders

GÅL Pharma AB (founders and management)15,50%
Indavvio AB (founders and management)15,50%
Prolajm AB (management)7,70%
Venture Holdings AB (founders and management)7,20%
Other investors ( external shareholders)54,10%